Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9726343 | 1.00 | CA12 (0.47) | CA12CA2CA3CA4CA6 | |
| Hydrochloric Acid SCHEMBL7645574 | 0.94 | CA12 (0.42) | CA12CA2CA3CA4CA6 | |
| Hydrochloric Acid SCHEMBL7645573 | 0.94 | CA12 (0.42) | CA12CA2CA3CA4CA6 | |
| SCHEMBL8734138 | 0.93 | CA12 (0.47) | CA12CA2CA3CA4CA6 | |
| SCHEMBL5801656 | 0.86 | CA12 (0.50) | CA12CA2CA3CA4CA6 | |
| SCHEMBL15052708 | 0.84 | MEN1 (0.39) | ALDH1A1TSHRKDM4EMEN1POLB | |
| SCHEMBL232247 | 0.84 | MEN1 (0.39) | ALDH1A1TSHRKDM4EMEN1POLB | |
| SCHEMBL9009492 | 0.84 | CA12 (0.40) | CA12CA2CA3CA4CA6 | |
| SCHEMBL16526089 | 0.84 | CA12 (0.48) | CA12CA2CA3CA4CA6 | |
| SCHEMBL19212991 | 0.84 | CYP2C9 (0.36) | CA12CA2CA3CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12467134-B2 | Method for deposition of gallium-containing film with gallium precursors | L'Air Liquide, Societe Anonyme pour l'Etude et l'Exploitation des Procedés Georges Claude (FR) | 2025-11-11 | — | — | US | claimed |
| US-20240287675-A1 | GALLIUM PRECURSORS FOR DEPOSITION OF GALLIUM-CONTAINING OXIDE FILMS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L’EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2024-08-29 | — | — | US | claimed |
| EP-4355926-A1 | GALLIUM PRECURSORS FOR DEPOSITION OF GALLIUM-CONTAINING OXIDE FILMS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2024-04-24 | — | — | EP | claimed |
| WO-2022266449-A1 | GALLIUM PRECURSORS FOR DEPOSITION OF GALLIUM-CONTAINING OXIDE FILMS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2022-12-22 | — | — | WO | claimed |
| EP-3708370-A1 | 3D-PRINTING METHOD USING GAS-ACTIVATED CYANOACRYLATES | Henkel AG & Co. KGaA (DE) | 2020-09-16 | — | — | EP | claimed |
| US-9611348-B2 | Process of producing polyolefins using metallocene polymerization catalysts and copolymers therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-04-04 | — | — | US | claimed |
| EP-3144072-A1 | DISPENSER, KIT AND METHOD FOR APPLYING AN ACTIVATOR FOR A CURABLE CYANOACRYLATE-BASED COMPONENT | Henkel AG & Co. KGaA (DE) | 2017-03-22 | — | — | EP | claimed |
| EP-2026896-B1 | CARBON DIOXIDE ABSORBENT REQUIRING LESS REGENERATION ENERGY | BASF SE (DE) | 2016-08-03 | — | — | EP | claimed |
| US-20140171431-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) | 2014-06-19 | — | — | US | claimed |
| EP-2725024-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2014-04-30 | — | — | EP | claimed |
| US-6559163-B2 | Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression | NEUROGEN CORPORATION | 2003-05-06 | — | — | US | claimed |
| US-6479672-B1 | Diastereoselective preparation of Michael adducts | MERCK & CO., INC. | 2002-11-12 | — | — | US | claimed |
| US-20020161008-A1 | 2,4-Substituted pyridine derivatives | NEUROGEN CORPORATION | 2002-10-31 | — | — | US | claimed |
| WO-2000061572-A1 | DIASTEREOSELECTIVE PREPARATION OF MICHAEL ADDUCTS | MERCK & CO., INC. (US) | 2000-10-19 | — | — | WO | claimed |
| US-6071561-A | Chemical vapor deposition of fluorine-doped zinc oxide | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-06-06 | — | — | US | claimed |
| EP-0559835-B1 | CONSUMER POLYOLEFIN PRIMER | LOCTITE CORP (US) | 1998-06-17 | — | — | EP | claimed |
| WO-1998008245-A2 | CHEMICAL VAPOR DEPOSITION OF FLUORINE-DOPED ZINC OXIDE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-02-26 | — | — | WO | claimed |
| US-5314562-A | Bonding a plastic substrate with an alpha-cyanoacrylate adhesive in which a primer comprising an ethylenediamine is used | LOCTITE CORPORATION (US) | 1994-05-24 | — | — | US | claimed |
| EP-0559835-A1 | CONSUMER POLYOLEFIN PRIMER | LOCTITE CORPORATION (US) | 1993-09-15 | — | — | EP | claimed |
| WO-1992009669-A1 | CONSUMER POLYOLEFIN PRIMER | LOCTITE CORPORATION (US) | 1992-06-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140171431-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | PLA2G5, LTA4H, PLA2G4A | CA12 957/4885CA2 518/4885CA3 1415/4885 |
| US-20240287675-A1 | GALLIUM PRECURSORS FOR DEPOSITION OF GALLIUM-CONTAINING OXIDE FILMS | NCOR2, GRIA2, GLRA2 | CA12 3314/4885CA2 1993/4885CA3 1521/4885 |
| US-20020161008-A1 | 2,4-Substituted pyridine derivatives | GABARAP, GABRB1, GABARAPL1 | CA12 4798/4885CA2 3278/4885CA3 1912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.